You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Claims for Patent: 9,125,816

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,125,816

Title:	Pharmaceutical composition and method for treating hypogonadism
Abstract:	A pharmaceutical composition useful for treating hypogonadism is disclosed. The composition comprises an androgenic or anabolic steroid, a C1-C4 alcohol, a penetration enhancer such as isopropyl myristate, and water. Also disclosed is a method for treating hypogonadism utilizing the composition.
Inventor(s):	Dudley; Robert E. (Kenilworth, IL), Drouin; Dominique (Verrieres le Buisson, FR)
Assignee:	BESINS HEALTHCARE INC. (Herndon, VA) UNIMED PHARMACEUTICALS, LLC (Abbott Park, IL)
Application Number:	13/965,499
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,125,816
Patent Claims:	1. A method of administering testosterone to human males for treating hypogonadism, the method comprising the step of: administering once per day a therapeutically effective dose of a pharmaceutical composition to human males, the pharmaceutical composition consisting of: (i) 0.1% to 10% (w/w) testosterone; (ii) 0.10% to 5.0% (w/w) isopropyl myristate; (iii) 30.0% to 98.0% (w/w) of ethanol, isopropanol or combinations thereof; (iv) 0.1% to 5.0% of a polyacrylic acid, wherein the polyacrylic acid is neutralized with sodium hydroxide; and (v) water wherein the administration is sufficient for the testosterone to reach the bloodstream of the human males to achieve a steady state pharmacokinetic profile similar to the pharmacokinetic profile for a testosterone gel shown in FIG. 5c, further wherein the administration of the pharmaceutical composition results in continuous transdermal delivery of testosterone for at least 24 hours, and still further wherein the administration of the pharmaceutical composition is as a gel and not as part of a patch. 2. The method of claim 1, wherein the sodium hydroxide is 0.1 N NaOH. 3. The method of claim 1, wherein the composition consists of testosterone, isopropyl myristate, ethanol, polyacrylic acid neutralized with sodium hydroxide and water. 4. The method of claim 3, wherein the ethanol is 95% (v/v) ethanol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.